Carmen de Mendoza

Carmen de Mendoza

UNVERIFIED PROFILE

Are you Carmen de Mendoza?   Register this Author

Register author
Carmen de Mendoza

Carmen de Mendoza

Publications by authors named "Carmen de Mendoza"

Are you Carmen de Mendoza?   Register this Author

100Publications

1652Reads

-Profile Views

HIV co-infection in HTLV-1 carriers in Spain.

Virus Res 2019 Jun 15;266:48-51. Epub 2019 Apr 15.

UNIR Health Sciences School & Medical Center, Madrid, Spain. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01681702193017
Publisher Site
http://dx.doi.org/10.1016/j.virusres.2019.04.004DOI Listing
June 2019

Benefits of hepatitis C cure with antivirals: why test and treat?

Future Microbiol 2019 Mar 22;14:425-435. Epub 2019 Mar 22.

Internal Medicine Department, Hospital Puerta de Hierro-Majadahonda, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fmb-2019-0041DOI Listing
March 2019

Prevalence and incidence of hepatitis delta in patients with chronic hepatitis B in Spain.

Eur J Gastroenterol Hepatol 2018 09;30(9):1060-1062

Infectious Diseases Unit, La Paz University Hospital.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MEG.0000000000001163DOI Listing
September 2018

Short article: Hepatitis delta in patients with resolved hepatitis B virus infection.

Eur J Gastroenterol Hepatol 2018 09;30(9):1063-1065

Infectious Diseases Unit, La Paz University Hospital.

View Article

Download full-text PDF

Source
http://Insights.ovid.com/crossref?an=00042737-201809000-0001
Publisher Site
http://dx.doi.org/10.1097/MEG.0000000000001187DOI Listing
September 2018

Impact of ITPA gene polymorphisms on the risk of ribavirin-induced haemolytic anaemia using interferon-free antivirals for chronic hepatitis C.

Antivir Ther 2017 15;22(7):571-575. Epub 2017 Feb 15.

Department of Internal Medicine & Liver Transplantation Unit, Puerta de Hierro Research Institute & University Hospital, Majadahonda, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3851/IMP3138DOI Listing
July 2018

Rate and predictors of treatment failure to all-oral HCV regimens outside clinical trials.

Antivir Ther 2017 24;22(4):307-312. Epub 2016 Jun 24.

Department of Internal Medicine, Puerta de Hierro Research Institute & University Hospital, Majadahonda, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3851/IMP3061DOI Listing
May 2018

Treatment and prevention of HIV infection with long-acting antiretrovirals.

Expert Rev Clin Pharmacol 2018 May 29;11(5):507-517. Epub 2018 Mar 29.

b Laboratory of Internal Medicine , Puerta de Hierro Research Institute , Majadahonda , Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17512433.2018.1453805DOI Listing
May 2018

Baseline NS5A resistance associated substitutions may impair DAA response in real-world hepatitis C patients.

J Med Virol 2018 03 3;90(3):532-536. Epub 2017 Nov 3.

Internal Medicine Department, Puerta de Hierro Research Institute and University Hospital, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jmv.24971DOI Listing
March 2018

High serum HCV RNA in chronic hepatitis C patients coinfected with HIV despite successful antiretroviral therapy.

Antivir Ther 2016 18;21(6):489-494. Epub 2016 Feb 18.

Infectious Diseases Unit, La Paz University Hospital, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3851/IMP3038DOI Listing
January 2018

Decline and changing profile of hepatitis delta among injection drug users in Spain.

Antivir Ther 2018 ;23(1):87-90

Infectious Diseases Unit, La Paz University Hospital & Autonomous University, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3851/IMP3161DOI Listing
January 2018

Hot News: HIV Epidemics - Current Burden and Future Prospects.

AIDS Rev 2017 Oct-Dec;19(4):239

Puerta de Hierro Research Institute, Majadahonda, Spain.

View Article

Download full-text PDF

Source
January 2018

Need to Face Liver Cirrhosis after HCV Cure with Antivirals.

EBioMedicine 2017 10 25;24:24-25. Epub 2017 Aug 25.

Liver Transplantation Unit, Internal Medicine Department, Puerta de Hierro Research Institute, Majadahonda, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ebiom.2017.08.022DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5651974PMC
October 2017

Evaluation of sofosbuvir, velpatasvir plus voxilaprevir as fixed-dose co-formulation for treating hepatitis C.

Expert Opin Drug Metab Toxicol 2017 Sep 28;13(9):1015-1022. Epub 2017 Jul 28.

b Department of Internal Medicine , Puerta de Hierro Research Institute , Majadahonda , Spain.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/17425255.2017.1
Publisher Site
http://dx.doi.org/10.1080/17425255.2017.1359254DOI Listing
September 2017

Dual antiretroviral therapy for HIV infection.

Expert Opin Drug Saf 2017 Aug 11;16(8):923-932. Epub 2017 Jul 11.

d Internal Medicine Department , Nuestra Señora de la Paz Hospital , Madrid , Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14740338.2017.1343300DOI Listing
August 2017

Treatment of hepatitis C with new fixed dose combinations.

Expert Opin Pharmacother 2017 Aug 30;18(12):1235-1242. Epub 2017 Jul 30.

a Infectious Diseases Unit, La Paz University Hospital & Autonomous University , Madrid , Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14656566.2017.1346609DOI Listing
August 2017

Drug interactions in HIV-infected patients treated for hepatitis C.

Expert Opin Drug Metab Toxicol 2017 Aug 13;13(8):807-816. Epub 2017 Jul 13.

a Infectious Diseases Unit , La Paz University Hospital , Madrid , Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17425255.2017.1351942DOI Listing
August 2017

New antivirals for the treatment of chronic hepatitis B.

Expert Opin Investig Drugs 2017 Jul 26;26(7):843-851. Epub 2017 May 26.

b Department of Internal Medicine , Puerta de Hierro Research Institute , Majadahonda , Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/13543784.2017.1333105DOI Listing
July 2017

Human T-lymphotropic virus type 1 infection and disease in Spain.

AIDS 2017 07;31(12):1653-1663

aPuerta de Hierro Research Institute, Majadahonda, Madrid bHospital Vall d'Hebrón, Barcelona cHospital de Conxo-CHUS, Santiago de Compostela dClinic University Hospital, Valladolid eBlood and Tissue Bank, Barcelona fRegional Transfusion Center, Madrid gCentro de Hemoterapia de Castilla-León, Valladolid hHospital Miguel Servet, Zaragoza iHospital Clínico Universitario Lozano Blesa, Zaragoza jUniversity Clinic kComplejo Hospitalario, Pamplona lCentro Sanitario Sandoval, Madrid mCristal-Piñor Hospital, Orense nGeneral Hospital, Alicante oHospital Virgen del Rocío, CIBERESP, Seville pRio Ortega Hospital, Valladolid qLa Paz University Hospital, Autonomous University, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0000000000001527DOI Listing
July 2017

HIV type 2 epidemic in Spain: challenges and missing opportunities.

AIDS 2017 06;31(10):1353-1364

aPuerta de Hierro Research Institute, Madrid bHospital de Poniente, Almeria cHospital Vall d'Hebrón, Barcelona dCorporación Sanitaria Parc Taulí, Sabadell eSon Espases Hospital, Palma de Mallorca fHospital Marqués de Valdecilla, Santander gFundación Jiménez Díaz, Madrid hGeneral Hospital, Alicante iLa Paz University Hospital & Autonomous University, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0000000000001485DOI Listing
June 2017

Does HIV Influence Hepatitis C Cure Rates Using Direct-Acting Antivirals?

AIDS Rev 2016 Apr-Jun;18(2):112-3

Department of Internal Medicine, Puerta de Hierro Research Institute, Majadahonda, Spain.

View Article

Download full-text PDF

Source
January 2017

HIV: Test and Treat, Please!

AIDS Rev 2016 Jul - Sep;18(3):166-167

Internal Medicine Department, Puerta de Hierro Research Institute & University Hospital, Majadahonda, Madrid, Spain.

View Article

Download full-text PDF

Source
January 2017

Risk of HIV Escape using Sub-Optimal Antiretroviral Dual or Monotherapy.

AIDS Rev 2016 Oct-Dec;18(4):223

Department of Internal Medicine, Puerta de Hierro Research Institute, Majadahonda, Spain.

View Article

Download full-text PDF

Source
January 2017

Hepatic decompensation with sofosbuvir plus simeprevir in a patient with Child-Pugh B compensated cirrhosis.

Antivir Ther 2016 4;21(1):91-2. Epub 2015 Jun 4.

Infectious Diseases Unit & IdiPAZ, La Paz University Hospital, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3851/IMP2969DOI Listing
December 2016

Hepatitis C cure with antiviral therapy--benefits beyond the liver.

Antivir Ther 2016 25;21(1):1-8. Epub 2015 Jun 25.

Infectious Diseases Unit, La Paz University Hospital & IdiPAZ, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3851/IMP2975DOI Listing
December 2016

The Burden of Neglected HIV-2 and HTLV-1 Infections in Spain.

AIDS Rev 2015 Oct-Dec;17(4):212-9

Infectious Diseases Unit, La Paz University Hospital IdiPAZ, Madrid, Spain.

View Article

Download full-text PDF

Source
September 2016

Hepatitis B Reactivation During Successful HCV Therapy.

AIDS Rev 2015 Jul-Sep;17(3):186

Department of Internal Medicine, Puerta de Hierro Research Institute and University Hospital, Madrid, Spain.

View Article

Download full-text PDF

Source
August 2016

Hypoglycemia in a diabetic patient during hepatitis C therapy.

Hepatology 2016 06 26;63(6):2065-6. Epub 2015 Nov 26.

Department of Internal Medicine, Puerta de Hierro Research Institute, Majadahonda, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.28137DOI Listing
June 2016

New hepatitis C therapies for special patient populations.

Expert Opin Pharmacother 2016 23;17(2):217-29. Epub 2015 Nov 23.

a Infectious Diseases Unit , La Paz University Hospital , Madrid 28046 , Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14656566.2016.1112790DOI Listing
June 2016

Prevention and management of treatment failure to new oral hepatitis C drugs.

Expert Opin Pharmacother 2016 Jun 9;17(9):1215-23. Epub 2016 May 9.

b Infectious Diseases Unit , La Paz University Hospital , Madrid , Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14656566.2016.1182156DOI Listing
June 2016

Acute hepatitis C virus re-infection in a heterosexual HIV-positive partner.

Liver Int 2016 05 1;36(5):763. Epub 2015 Jun 1.

Infectious Diseases Unit & IdiPAZ, La Paz University Hospital, Madrid, Spain.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/liv.12858
Publisher Site
http://dx.doi.org/10.1111/liv.12858DOI Listing
May 2016

Dual antiviral therapy for HIV and hepatitis C - drug interactions and side effects.

Expert Opin Drug Saf 2015 28;14(9):1421-34. Epub 2015 Jul 28.

a 1 La Paz University Hospital, Infectious Diseases Unit , Madrid, Spain +34 91 7277000 ;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14740338.2015.1073258DOI Listing
May 2016

Tenofovir for Hepatitis Delta.

Hepatology 2016 Apr 28;63(4):1395-6. Epub 2015 Jul 28.

Puerta de Hierro Research Institute & University Hospital, Majadahonda, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.27946DOI Listing
April 2016

Liver fibrosis progression despite HCV cure with antiviral therapy in HIV-HCV-coinfected patients.

Antivir Ther 2015 5;20(3):329-34. Epub 2014 Nov 5.

Department of Infectious Diseases, Hospital Carlos III, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3851/IMP2909DOI Listing
February 2016

Long-term survival and liver-related events after pegylated interferon/ribavirin therapy in HIV-infected patients with chronic hepatitis C.

Antivir Ther 2015 8;20(1):65-72. Epub 2014 Aug 8.

Department of Infectious Diseases, Hospital Carlos III, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3851/IMP2827DOI Listing
November 2015

Rate and predictors of serum HCV-RNA >6 million IU/mL in patients with chronic hepatitis C.

J Clin Virol 2015 Oct 13;71:63-6. Epub 2015 Aug 13.

Infectious Diseases Unit, La Paz University Hospital, Madrid, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcv.2015.08.001DOI Listing
October 2015

Progression to advanced liver fibrosis in HIV-HCV-coinfected patients and prioritization of new hepatitis C therapies.

Antivir Ther 2014 25;19(8):799-803. Epub 2014 Jun 25.

Department of Infectious Diseases, Hospital Carlos III, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3851/IMP2816DOI Listing
September 2015

Emerging challenges in managing hepatitis B in HIV patients.

Curr HIV/AIDS Rep 2015 Sep;12(3):344-52

Infectious Diseases Unit, La Paz University Hospital, Madrid, Spain,

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11904-015-0275-7
Publisher Site
http://dx.doi.org/10.1007/s11904-015-0275-7DOI Listing
September 2015

Very late HCV relapse following triple therapy for hepatitis C.

Antivir Ther 2014 17;19(7):723-4. Epub 2014 Feb 17.

Department of Infectious Diseases, Hospital Carlos III, Madrid, Spain.

View Article

Download full-text PDF

Source
http://www.intmedpress.com/journals/avt/abstract.cfm?id=2753
Publisher Site
http://dx.doi.org/10.3851/IMP2753DOI Listing
August 2015

HIV-2 and HTLV-1 infections in Spain, a non-endemic region.

AIDS Rev 2014 Jul-Sep;16(3):152-9

Department of Infectious Diseases, Hospital Carlos III, Madrid; Department of Internal Medicine, La Paz University Hospital, Madrid, Spain.

View Article

Download full-text PDF

Source
March 2015

Controlling HIV epidemics is feasible but HIV eradication remains elusive.

AIDS Rev 2014 Jul-Sep;16(3):183

Department of Internal Medicine, Puerta de Hierro Research Institute and University Hospital, Majadahonda, Spain.

View Article

Download full-text PDF

Source
March 2015

Gene therapy for HIV infection.

Expert Opin Biol Ther 2015 Mar 17;15(3):319-27. Epub 2014 Oct 17.

Puerta de Hierro Research Institute and University Hospital, Department of Internal Medicine , Majadahonda, Madrid , Spain

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14712598.2015.967208DOI Listing
March 2015

Drug interactions with new hepatitis C oral drugs.

Expert Opin Drug Metab Toxicol 2015 Mar 2;11(3):333-41. Epub 2015 Jan 2.

IdiPAZ-La Paz University Hospital and Autonomous University, Infectious Diseases Unit , Madrid , Spain

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/17425255.2015.998997DOI Listing
March 2015

Dolutegravir for the treatment of HIV-2 infection.

J Clin Virol 2015 Mar 5;64:12-5. Epub 2015 Jan 5.

Infectious Diseases Unit, La Paz University Hospital & IdiPAZ, Paseo de la Castellana 261, Madrid 28046, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcv.2015.01.001DOI Listing
March 2015

Advances in treating drug-resistant hepatitis B virus in HIV-infected patients.

Expert Opin Pharmacother 2015 Feb 22;16(2):179-86. Epub 2014 Dec 22.

Department of Internal Medicine and Infectious Diseases , La Paz University Hospital , Spain

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14656566.2015.973852DOI Listing
February 2015

HIV drug resistance testing still important.

AIDS Rev 2014 Jan-Mar;16(1):54-5

Department of Internal Medicine. Hospital Universitario Puerta de Hierro. Puerta de Hierro Research Institute. Madrid, Spain.

View Article

Download full-text PDF

Source
December 2014

Very late relapse after discontinuation of antiviral therapy for chronic hepatitis C.

Antivir Ther 2013 27;18(8):1033-5. Epub 2013 Jun 27.

Department of Infectious Diseases, Hospital Carlos III, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3851/IMP2659DOI Listing
October 2014

Efficacy of prolonged tenofovir therapy on hepatitis delta in HIV-infected patients.

AIDS 2014 Oct;28(16):2389-94

aDepartment of Infectious Diseases, Hospital Carlos III bDepartment of Internal Medicine, La Paz University Hospital cDepartment of Internal Medicine, Puerta de Hierro Research Institute & University Hospital, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0000000000000417DOI Listing
October 2014

Spontaneous hepatitis C virus clearance in one HIV patient with chronic hepatitis C bearing IL28B-CC alleles and detectable plasma HIV-RNA.

AIDS 2014 Sep;28(14):2169-70

aInternal Medicine Department, Hospital Universitario Puerta de Hierro-Majadahonda bPuerta de Hierro Research Institute cMicrobiology Deparment, Hospital Universitario Puerta de Hierro dUniversidad Autónoma, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0000000000000391DOI Listing
September 2014

Management and treatment of chronic hepatitis B in HIV-positive patients.

Ann Med 2014 Aug 10;46(5):290-6. Epub 2014 Apr 10.

Department of Infectious Diseases , Hospital Carlos III, Madrid , Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/07853890.2014.899103DOI Listing
August 2014

HIV-2 viral tropism influences CD4+ T cell count regardless of viral load.

J Antimicrob Chemother 2014 Aug 30;69(8):2191-4. Epub 2014 Apr 30.

Hospital Carlos III, Madrid, Spain Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jac/dku119DOI Listing
August 2014

Pharmacogenetics of antiretroviral therapy.

Expert Opin Drug Metab Toxicol 2014 Aug 18;10(8):1119-30. Epub 2014 Jun 18.

Hospital Carlos III, Department of Infectious Diseases , Calle Sinesio Delgado 10, Madrid 28029 , Spain

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/17425255.2014.930128DOI Listing
August 2014

X4 tropic viruses are on the rise in recent HIV-1 seroconverters in Spain.

AIDS 2014 Jul;28(11):1603-9

aHospital Carlos III bCentro Sanitario Sandoval, Madrid cHospital Conxo-CHUS, Santiago dHospital General, Elche & Universidad Miguel Hernández, Alicante eHospital Rio Hortega, Valladolid fHospital Vall d'Hebron, Barcelona gHospital Universitario Puerta de Hierro & Puerta de Hierro Research Institute, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0000000000000269DOI Listing
July 2014

Towards hepatitis C eradication from the HIV-infected population.

Antiviral Res 2014 May 15;105:1-7. Epub 2014 Feb 15.

Department of Infectious Diseases, Hospital Carlos III, Madrid, Spain. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01663542140003
Publisher Site
http://dx.doi.org/10.1016/j.antiviral.2014.02.004DOI Listing
May 2014

Dolutegravir, abacavir and lamivudine as HIV therapy.

Expert Opin Pharmacother 2014 May;15(7):1051-7

Hospital Carlos III, Department of Infectious Diseases , Madrid , Spain

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14656566.2014.913023DOI Listing
May 2014

Scaling up epidemics of acute hepatitis C and syphilis in HIV-infected men who have sex with men in Spain.

Liver Int 2013 Oct 3;33(9):1357-62. Epub 2013 Jun 3.

Department of Infectious Diseases, Hospital Carlos III, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/liv.12212DOI Listing
October 2013

Association between HLA alleles and HAM/TSP in individuals infected with HTLV-1.

J Neurol 2013 Oct 9;260(10):2551-5. Epub 2013 Jul 9.

Infectious Diseases Department, Hospital Carlos III, 10 Calle Sinesio Delgado, 28029, Madrid, Spain,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00415-013-7014-zDOI Listing
October 2013

Emerging viral infections‑-a potential threat for blood supply in the 21st century.

AIDS Rev 2012 Oct-Dec;14(4):279-89

Department of Infectious Diseases, Hospital Carlos III, Madrid, Spain.

View Article

Download full-text PDF

Source
June 2013

Hepatitis C therapy with HCV NS5B polymerase inhibitors.

Expert Opin Pharmacother 2013 Jun 27;14(9):1161-70. Epub 2013 Apr 27.

Hospital Carlos III, Department of Infectious Diseases, Calle Sinesio Delgado 10, Madrid 28029, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14656566.2013.795543DOI Listing
June 2013

Hepatitis B, C, and D and HIV infections among immigrants from Equatorial Guinea living in Spain.

Am J Trop Med Hyg 2013 Apr 21;88(4):789-94. Epub 2013 Jan 21.

Servicio de Enfermedades Infecciosas, Unidad de Medicina Tropical, Hospital Carlos III, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4269/ajtmh.12-0319DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3617871PMC
April 2013

Prevalence of xenotropic murine leukemia virus-related virus infection in different risk populations in Spain.

AIDS Res Hum Retroviruses 2012 Sep 21;28(9):1089-94. Epub 2012 Feb 21.

Infectious Diseases Department, Hospital Carlos III, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/AID.2011.0149DOI Listing
September 2012

Predicted effect of direct acting antivirals in the current HIV-HCV-coinfected population in Spain.

Antivir Ther 2012 15;17(3):571-5. Epub 2011 Dec 15.

Department of Infectious Diseases, Hospital Carlos III, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3851/IMP1992DOI Listing
August 2012

Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy.

Retrovirology 2012 Aug 13;9:68. Epub 2012 Aug 13.

Centro de Biología Molecular "Severo Ochoa", Consejo Superior de Investigaciones Científicas & Universidad Autónoma de Madrid, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1742-4690-9-68DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3468358PMC
August 2012

Rilpivirine: a next-generation non-nucleoside analogue for the treatment of HIV infection.

Expert Opin Pharmacother 2012 May;13(7):1007-14

Hospital Carlos III, Department of Infectious Diseases, Calle Sinesio Delgado 10, 28029 Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14656566.2012.667802DOI Listing
May 2012

Mechanisms involved in CD4 cell gains in HIV-infected patients switched to raltegravir.

AIDS 2012 Mar;26(5):551-7

Department of Infectious Diseases, Hospital Carlos III, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0b013e3283509826DOI Listing
March 2012

Plasma raltegravir exposure influences the antiviral activity and selection of resistance mutations.

AIDS Res Hum Retroviruses 2012 Feb 6;28(2):156-64. Epub 2011 May 6.

Infectious Diseases Department, Hospital Carlos III, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/AID.2010.0370DOI Listing
February 2012

Antiviral effect of raltegravir on HTLV-1 carriers.

J Antimicrob Chemother 2012 Jan 29;67(1):218-21. Epub 2011 Sep 29.

Infectious Diseases Department, Hospital Carlos III, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jac/dkr404DOI Listing
January 2012

Drug resistance mutations in patients infected with HIV-2 living in Spain.

J Antimicrob Chemother 2011 Jul 10;66(7):1484-8. Epub 2011 May 10.

Infectious Diseases Department, Hospital Carlos III, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jac/dkr164DOI Listing
July 2011

Resistance associated mutations to dolutegravir (S/GSK1349572) in HIV-infected patients--impact of HIV subtypes and prior raltegravir experience.

Antiviral Res 2011 Jun 23;90(3):164-7. Epub 2011 Mar 23.

Infectious Diseases Department, Hospital Carlos III, Calle Sinesio Delgado 10, 28029 Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.antiviral.2011.03.178DOI Listing
June 2011

Do integrase inhibitors impact on the HIV reservoir.

AIDS Rev 2010 Oct-Dec;12(4):243

View Article

Download full-text PDF

Source
May 2011

HIV-1 drug resistance testing from dried blood spots collected in rural Tanzania using the ViroSeq HIV-1 Genotyping System.

J Antimicrob Chemother 2011 Feb 25;66(2):260-4. Epub 2010 Nov 25.

Department of Infectious Diseases, Oslo University Hospital, Ulleval, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jac/dkq433DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3019084PMC
February 2011

Minority HIV mutation detection in dried blood spots indicates high specimen integrity and reveals hidden archived drug resistance.

J Clin Virol 2011 Feb 3;50(2):148-52. Epub 2010 Dec 3.

Laboratory Branch, Division of HIV/AIDS Prevention, National Centers for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, 1600 Clifton Rd., NE, MS G45 Atlanta, GA 30333, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcv.2010.11.006DOI Listing
February 2011